Madison, WI, United States of America

Aaron Almeida

This inventor holds 10 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Arrowhead Pharmaceuticals, Inc.. Active years: 2016-2024.

USPTO Granted Patents = 10 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 8.0

ph-index = 3

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Aaron Almeida in Cancer Therapeutics**

Introduction

Aaron Almeida, an accomplished inventor based in Madison, WI, has made significant strides in the field of biotechnology. With a remarkable portfolio of 10 patents, his work focuses on developing innovative therapeutic solutions aimed at combating cancer through advanced molecular techniques.

Latest Patents

Among his latest inventions are groundbreaking patents that detail the use of alpha-v beta-6 integrin ligands. These ligands possess serum stability and strong affinity for αvβ6 integrins, promising to enhance treatment methods. Additionally, Aaron has invented compositions and methods that employ RNA interference (RNAi) technology for inhibiting gene expression of Hif2alpha, which is critical in cancer progression. His work provides pharmaceutical compositions that can deliver these RNAi triggers effectively to tumor cells, thereby offering new avenues for cancer treatment.

Career Highlights

Aaron Almeida is currently a key figure at Arrowhead Pharmaceuticals, Inc., a company renowned for its innovative approaches to treating various diseases through RNA interference technologies. His dedication and ingenuity have positioned him as a crucial player in the ongoing battle against cancer, allowing for more targeted and effective therapeutic options.

Collaborations

Throughout his career, Aaron has collaborated with talented colleagues such as David B Rozema and Darren H Wakefield. This teamwork showcases a commitment to advancing cancer research and developing cutting-edge methodologies that hold the potential to save lives.

Conclusion

In summary, Aaron Almeida exemplifies what it means to be a forward-thinking inventor in the biotechnology sector. With his innovative patents and dedicated work at Arrowhead Pharmaceuticals, he is undoubtedly making a lasting impact on cancer treatment and research. As the field evolves, the contributions of inventors like Aaron will pave the way for future breakthroughs in medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…